- Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.details
|
|
Risk Communication for Nanobiotechnology: To Whom, About What, and Why?Susanna Hornig Priest - 2009 - Journal of Law, Medicine and Ethics 37 (4):759-769.details
|
|
Risk Communication for Nanobiotechnology: To Whom, about What, and Why?Susanna Hornig Priest - 2009 - Journal of Law, Medicine and Ethics 37 (4):759-769.details
|
|
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology.Jordan Paradise, Alison W. Tisdale, Ralph F. Hall & Efrosini Kokkoli - 2009 - Journal of Law, Medicine and Ethics 37 (4):598-624.details
|
|
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology.Jordan Paradise, Alison W. Tisdale, Ralph F. Hall & Efrosini Kokkoli - 2009 - Journal of Law, Medicine and Ethics 37 (4):598-624.details
|
|
Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms.Kristen C. Nelson, David A. Andow & Michael J. Banker - 2009 - Journal of Law, Medicine and Ethics 37 (4):732-748.details
|
|
Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms.Kristen C. Nelson, David A. Andow & Michael J. Banker - 2009 - Journal of Law, Medicine and Ethics 37 (4):732-748.details
|
|
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines.Jonathan Kimmelman - 2012 - Journal of Law, Medicine and Ethics 40 (4):841-847.details
|
|
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines.Jonathan Kimmelman - 2012 - Journal of Law, Medicine and Ethics 40 (4):841-847.details
|
|
A Portrait of Nanomedicine and Its Bioethical Implications.Rebecca M. Hall, Tong Sun & Mauro Ferrari - 2012 - Journal of Law, Medicine and Ethics 40 (4):763-779.details
|
|
A Portrait of Nanomedicine and its Bioethical Implications.Rebecca M. Hall, Tong Sun & Mauro Ferrari - 2012 - Journal of Law, Medicine and Ethics 40 (4):763-779.details
|
|
Adding to the Mix: Integrating ELSI into a National Nanoscale Science and Technology Center.David J. Bjornstad & Amy K. Wolfe - 2011 - Science and Engineering Ethics 17 (4):743-760.details
|
|